Back

The role of atrial pacing site in reducing filling pressures by accelerated pacing in virtual HFpEF patients

7 April 2024 (08:30 - 15:00)
Organised by: Logo
Congress Presentation Part of: Devices: bradycardia 1 Antibradycardia Pacing EHRA Premium Access EHRA 2024 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Mr Tim Van Loon

Cardiovascular Research Institute Maastricht (CARIM), Maastricht (Netherlands (The))

7 More presentations in this session

Presentation thumbnail
Outcomes of leadless pacemaker in chronic kidney disease patients: real-world data from the i-LEAPER registry
Doctor G. Mitacchione (Brescia, IT)
Abstract Slides Video
Presentation thumbnail
Outcomes of tine-based leadless pacemakers retrieval: a multicenter study
Doctor S. Jurisic (Zurich, CH)
Abstract Slides Video
Presentation thumbnail
Precordial activation sequences from low frequency analysis in left bundle branch block patients: left bundle branch area pacing vs right ventricular pacing
Miss C. Sales Belles (Zaragoza, ES)
Abstract Slides Video
Presentation thumbnail
Assessing V6 RWPT and V6-V1 interpeak time as conduction system capture criteria in non-basal LBBAP lead positions
Mr J. Rijks (Maastricht, NL)
Abstract Slides Video
Presentation thumbnail
Leadless pacemaker implantation via the internal jugular vein a promising access for an established intervention
Doctor N. Molitor (Zurich, CH)
Abstract Slides Video

Access the full session

Session thumbnail
Devices: bradycardia 1

The Event

Event poster

EHRA 2024

7 April - 9 April 2024
You may be interested in
thumbnail
Congress Presentation
Verification of intra- and inter-atrial conduction during Bachmann's bundle pacing using longitudinal bi-atrial strain
thumbnail
Congress Presentation
Impact of myocardial phenotype on atrioventricular delay optimization at rest and during exercise: insights from a virtual patient study
thumbnail
Congress Presentation
Reconstructing atrio-ventricular interaction in patients with atrial fibrillation with or without heart failure and preserved ejection fraction undergoing pulmonary vein isolation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources